Chimerism after organ transplantation

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 3, 1997, Pages 292-298

  Starzl, Thomas E ^a   Demetris, Anthony J ^b   Murase, Noriko ^b   Trucco, Massimo ^b   Thomson, Angus W ^b   Rao, Abdul S ^b   Fung, John J ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLONY STIMULATING FACTOR; CYCLOSPORIN; CYTOKINE; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; OKT 3; RECEPTOR; STEM CELL FACTOR; TACROLIMUS;

ALLOGRAFT; ARTICLE; BLOOD TRANSFUSION; CHIMERA; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; XENOTRANSPLANTATION;

EID: 0030854033     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199705000-00015     Document Type: Article

References (52)

1. Starzl TE, Demetris AJ, Murase N, Ildslad S, Ricordi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 1992, 339:1579-1582.
2. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ et al.: Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993, 17:1127-1152.
3. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice, I. Morphology, quantitation, tissue distribution. J Exp Med 1973, 137:1142-1162.
4. Schlitt HJ, Hundrieser J, Hisanaga M, Uthoff K, Karck M, Wahlers T, Wonigeit K, Pichlmayr R: Patterns of donor-type microchimerism after heart transplantation. Lancet 1994, 343:1469-1471.
5. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE: Hematolymphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993, 25:3337-3344.
6. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE: Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994, 19:916-924.
7. Murase N, Starzl TE, Tanabe M, Fujisaki S, Miyazawa H, Ye Q, Delaney CP, Fung JJ, Demetris AJ: Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats. Transplantation 1995, 60:158-171.
8. Starzl TE, Demetris AJ: Transplantation milestones: viewed with one- and two-way paradigms of tolerance. JAMA 1995, 273:876-879.
9. Przepiorka D, Thomas ED, Durham DM, Fisher L: Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. Am J Clin Pathol 1991, 95:201-206.
10. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS: The lost chord: microchimerism. Immunol Today 1996, 17:577-584. Most complete overview on microchimerism since its discovery in 1992 in organ transplant recipients.
11. Starzl TE, Marchioro TL, Waddell WR: The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963, 117:385-395.
12. Morecki S, Leshem B, Eid A, Slavin S: Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med 1987, 165:1468-1480.
13. Bushell A, Pearson TC, Morris PJ, Wood KJ: Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Transplantation 1995, 59:1367-1371.
14. Wood K, Sachs DH: Chimerism and transplantation tolerance: cause and effect Immunol Today 1996, 17:584-587. Argument that microchimerism is an epiphenomen, rather than the cause, of organ allograft acceptance.
15. Murase N, Demetris AJ, Tsamandas AC, Ye Q, Starzl TE: The heterogenous distribution of chimerism produced by rat organ and bone marrow allotransplantation. Transplantation 1996, 61:1126-1131.
16. - lymphoproliferative disorders arising in organ transplant recipients. Transplantation 1997, 63:1200-1205. The seminal role is described of microchimerism in the pathogenesis of posttransplant lymphoproliferative disorders.
17. Schwartz R, Andre-Schwartz J, Armstrong MYK, Beldotti L: Neoplastic sequelae of allogenic disease, I. Theoretical considerations and experimental design. Ann NY Acad Sci 1966, 129:804-821.
18. Penn I, Hammond W, Brettschneider L, Starzl TE: Malignant lymphomas in transplantation patients. Transplant Proc 1969, 1:106-112.
19. Starzl TE, Penn I, Putnam CW, Groth CG, Halgrimson CG: Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 1971, 7:112-145.
20. Klein G, Klein E: Evolution of tumours and the impact of molecular oncology. Nature 1985, 315:190-195.
21. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL et al.: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984, 1:583-587.
22. Nalesnik MA, Makowka L, Starzl TE: The diagnosis and treatment of post transplant lymphoproliferative disorders. In Current Problems in Surgery. Edited by Ravitch M. Chicago, Illinois: Year Book Medical Publishers, Inc.; 1988, 25:367-472.
23. Reyes J, Zeevi A, Ramos H, Todo S, Demetris AJ, Nour B, Nalesnik M, Trucco M, Abu-Elmagd K, Fung JJ, Starzl TE: Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 1993, 25:3315-3319.
24. Klein G: The Epstein-Barr virus and neoplasia. N Engl J Med 1975, 293:1353-1357.
25. Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994, 77:791-793.
26. Khanna R, Burrows SR, Moss DJ: Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 1995, 59:387-405.
27. Masucci MG: Viral immunopathology of human tumors. Curr Opin Immunol 1993, 5:693-700.
28. Calne RY, Rolles K, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Henderson RG, Aziz S, Lewis P: Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979, ii:1033-1036.
29. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM, Berquist WE, So SKS, Esquivel CO: An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995, 59:524-529.
30. An account of a large experience with tacrolimus in pediatric renal transplant recipients with emphasis on their better quality of life and morbidity.
31. Salvatierra O Jr, Vincenti F, Amend WJ, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D et al.: Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980, 192:543-552.
32. Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW: Possible active enhancement of human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt Surgery 1976, 79:384-392.
33. Barber WH, Mankin JA, Laskow DA, Dierhoi MH, Julian BA, Curtis JJ, Diethelm AG: Long term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991, 51:70-75.
34. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C: Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation, Immunol Today 1993, 14:326-332.
35. Fontes P, Rao A, Demetris AJ, Zeevi A, Trucco M, Carroll P, Rybka W, Ricordi C, Dodson F, Shapiro R et al.: Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 1994, 344:151-155.
36. Rao AS, Fontes P, Dodson F, Zeevi A, Rugeles MT, Abu-Elmagd K, Aitouche A, Rosner G, Trucco M, Demetris AJ et al.: Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc 1996, 28:2959-2965. First proof of augmented precursor stem cell engraftment in kidney recipients given simultaneous donor bone marrow.
37. Shapiro R, Rao AS, Fontes P, Zeevi A, Jordan M, Scantlebury VP, Vivas C, Gritsch A, Corry RJ, Egidi F et al.: Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995, 60:1421-1425.
38. Garcia Morales R, Esquenazi V, Zucker K, Gomez CI, Fuller L, Carreno M, Cirocco R, Alamo A, Karatzas T, Burke GW III et al.: Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-FLOW). Transplantation 1996, 62:1149-1160. The findings in reference 38 were verified using a novel detection technique.
39. Lyman SD, James L, Bos TV, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha S, McKenna HJ, Splett RR et al.: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993, 75:1157-1167.
40. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J et al.: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994, 368:643-648.
41. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann P, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994, 83:2795-2801.
42. Jacobsen SEW, Okkenhaug C, Myklebust J, Veilby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 1995, 181:1357-1363.
43. - cells and maintains progenitor cells in vitro. Blood 1996, 87:3563-3570. This is the first description in humans of augmented circulating progenitor and stem cells following treatment with the most potent known hemotolymphopoietic growth factor.
44. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R: FLK2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995, 85:963-972.
45. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996, 184:1953-1962.
46. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE: Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995, 13:622-639. Summary of experimental evidence up to early autumn 1995 that dendritic cells can be tolerogenic as well as immunogenic.
47. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995, 60:1539-1545.
48. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW: GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995, 60:1366-1370.
49. dim, CD86 ) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 1996, 62:659-665. First direct demonstration that precursor dendritic cells induce donor-specific nonreactivity to concomitant transplanted organ allografts.
50. Vremec D, Lieschke GJ, Dunn AR, Robb L, Metcalf D, Shortman K: The influence of granulocyte-macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. J Eur Immunol 1997, 27:40-44.
51. Starzl TE, Todo S, Tzakis A, Alessiani M, Casavilla A, Abu-Elmagd K, Fung JJ: The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991, 172:335-344.
52. Starzl TE, Demetris AJ, Murase N, Valdivia L, Thomson AW, Fung J, Rao AS: The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc 1997, 29:19-27. Emphasizes the necessity of establishing chimerism if xenotransplantation is to be made feasible.